Your browser doesn't support javascript.
loading
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials.
Eleuteri, C; Olla, S; Veroni, C; Umeton, R; Mechelli, R; Romano, S; Buscarinu, M C; Ferrari, F; Calò, G; Ristori, G; Salvetti, M; Agresti, C.
Afiliação
  • Eleuteri C; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Olla S; Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Monserrato 09042, Italy.
  • Veroni C; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Umeton R; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Mechelli R; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Romano S; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Buscarinu MC; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Ferrari F; Department of Medical Science, Section of Pharmacology and National Institute of Neuroscience, University of Ferrara, 44121 Ferrara, Italy.
  • Calò G; Department of Medical Science, Section of Pharmacology and National Institute of Neuroscience, University of Ferrara, 44121 Ferrara, Italy.
  • Ristori G; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Salvetti M; Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.
  • Agresti C; IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, 86077 Pozzilli, IS, Italy.
Sci Rep ; 7: 45780, 2017 04 07.
Article em En | MEDLINE | ID: mdl-28387380
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Avaliação Pré-Clínica de Medicamentos / Células Precursoras de Oligodendrócitos / Remielinização Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Avaliação Pré-Clínica de Medicamentos / Células Precursoras de Oligodendrócitos / Remielinização Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article